A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors

NCT05908773 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TTX-MC138-NODAGA-Cu64

Sponsor

TransCode Therapeutics